The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong anticoagulation therapy. However, the bleeding risk and recurrence of venous thromboembolism (VTE) in CTEPH patients who are administered warfarin have not been adequately evaluated. The purpose of this study was to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pulm Circ
Main Authors: Jujo-Sanada, Takayuki, Tanabe, Nobuhiro, Sakao, Seiichiro, Sugiura, Toshihiko, Sekine, Ayumi, Nishimura, Rintaro, Suda, Rika, Naito, Akira, Miwa, Hideki, Yamamoto, Keiko, Sasaki, Akane, Matsumura, Akane, Ema, Ryogo, Kasai, Hajime, Kato, Fumiaki, Tatsumi, Koichiro
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2017
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841905/
https://ncbi.nlm.nih.gov/pubmed/28604280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045893217717258
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares